Data Characteristics for this Category
Documents generated by Chief Scientific Officer (CSO) teams in biopharmaceutical R&D primarily include experimental reports, preclinical study data, patent analyses, technical evaluation reports, and project proposals. These documents originate from various sources, such as internal experimental platforms, external collaborators, and database search results. Update frequency typically aligns with R&D project cycles, ranging from weekly to quarterly, but core data changes relatively slowly. Document structures are complex, often containing non-textual content like charts, chemical structures, sequence information, and statistical data. Textual sections are highly specialized, filled with biological, chemical, and medical terminology, as well as specific abbreviations and units like nM (nanomolar), μg/mL (micrograms per milliliter), and EC50 (half maximal effective concentration). Field names are often not standardized; for example, "Compound ID" might appear as Compound ID, CMPD No., or 分子编码.
Constraints Imposed by These Characteristics on Citation and Traceability
The specialized nature and complex structure of CSO documents demand high accuracy in citation sources. Extensive technical terminology and abbreviations mean simple semantic matching can lead to incorrect or missed citations. The embedding of non-textual information like charts and chemical structures implies that relying solely on text segmentation cannot capture the full context. Irregular update frequencies require knowledge bases to effectively manage versions, preventing the citation of outdated information. Non-standardized field names, such as Target ID and 靶点编号, increase the difficulty of unified retrieval and traceability. The precision of measurement units, like IC50 values, can lead to severe consequences if cited incorrectly. Therefore, cited content must exactly match the data in the original document and be traceable to specific values. These constraints collectively necessitate more refined segmentation strategies, more robust entity recognition capabilities, and version management mechanisms for citation and traceability.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk Length | 300–500 characters | Ensures each chunk contains sufficient context while avoiding excessive length that could lead to imprecise recall. CSO documents are highly specialized, and short chunks can lose context. |
Chunk Overlap | 100–150 characters | Promotes semantic coherence between paragraphs, especially when technical terms are dense or concepts span multiple paragraphs, improving recall completeness. |
Recall Count | Top 8–12 chunks | CSO document content is highly interconnected. Increasing recall quantity helps cover a wider range of potential citations, which are then optimized through reranking. |
Similarity Threshold | 0.75–0.85 | Balances precision and recall rate. Too low may introduce irrelevant citations; too high may miss important but slightly differently phrased professional content. |
Rerank Return Count | Top 3–5 chunks | Selects the most relevant citations for the user, reducing information overload while maintaining broad recall. |
Entity Recognition Model | Calibrated by actual measurement | Configures specialized entity recognition models for biological and medical terminology, compound names, target names, etc., to improve traceability accuracy. |
Three Common Mistakes
- Knowledge base citation results include paragraphs unrelated to the query content. This occurs when the
Similarity Thresholdis set too low, leading to the recall of semantically distant content. - Citations appear in the conversation, but users cannot locate the corresponding position in the original document by clicking a link. This happens because the segmentation strategy is not bound to document page numbers or specific anchors, preventing precise traceability.
- Outdated experimental data or project statuses are cited. This is due to the knowledge base not regularly synchronizing or updating source documents, or not having document version management enabled.
How to Verify Correct Configuration
- Randomly select more than 10 R&D questions with clear answers. Check if the citation results accurately pinpoint key information in the original documents and can be traced back to specific paragraphs or page numbers.
- Verify whether the knowledge base can accurately extract and cite relevant content when faced with queries containing specialized terminology, chemical structures, or tabular data, especially ensuring correct citation of critical values like
EC50andIC50. - Check if the knowledge base prioritizes citing the latest version of information after document updates and clearly identifies the document version number of the citation source, e.g.,
v1.2. - Confirm, by simulating questions, that the system does not provide any citation markers, such as
[1], when the knowledge base citation feature is disabled.
Note: The values provided are common starting points. Measure performance against your own samples to determine the optimal configuration.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.